Related Experiment Video
Updated: Jul 8, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Subcutaneous sumatriptan in an adolescent with acute posttraumatic headache.
Nicholas S Abend1, Michael L Nance, Carsten Bonnemann
1Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. abend@email.chop.edu
Journal of Child Neurology
|January 10, 2008
Summary
Acute posttraumatic headache can become chronic and disabling. Subcutaneous sumatriptan rapidly improved headache and migrainous features in an adolescent unresponsive to other treatments.
Area of Science:
- Neurology
- Trauma Care
Background:
- Acute posttraumatic headache (APTH) is a frequent consequence of head injury.
- APTH can transition into chronic posttraumatic headache (CPTH), leading to medication overuse and disability.
- Limited evidence exists for effective APTH treatment strategies.
Observation:
- An adolescent patient presented with APTH refractory to multiple initial pharmacotherapies.
- The patient experienced significant and persistent relief from headache and associated migrainous symptoms following subcutaneous sumatriptan administration.
Findings:
- Subcutaneous sumatriptan demonstrated rapid and sustained efficacy in managing refractory APTH.
- This treatment also resolved associated migrainous features, suggesting a potential role in broader symptom management.
Implications:
- Subcutaneous sumatriptan may represent a viable therapeutic option for adolescents with severe APTH.
- Further research is warranted to establish optimal treatment protocols for APTH and prevent its chronification.
